Koninklijke Philips N.V. NY Reg (PHG) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.45
- Estimate
- $0.36
- Surprise
- +24.4%
- Score at report (before → after)
- 5.8 → 5.9/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Koninklijke Philips N.V. NY Reg (PHG) beat the $0.36 estimate with adjusted EPS of $0.45 — a large 24.4% upside surprise. TrendMatrix's engine moved from Buy (Wait) (5.8/10) to Hold at 5.9/10 after the report.
Coverage in the report window
- Philips Reports Strong Customer Demand, Improved Profitability — benzinga, 2026-11-03
- Philips Says Productivity Programme Delivered €170M Net Savings In Q3; On Track For €1.5B 2026–2028 — benzinga, 2026-11-03
- Philips Q3 Free Cash Flow €384M vs €172M Y/Y — benzinga, 2026-11-03
Where TrendMatrix's rating stands now
TrendMatrix currently rates PHG Hold at 5.9/10.
4 of the last 4 quarters beat the estimate; this quarter's +24.4% surprise compares with a +40.1% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Analyst target reached - limited upside remaining
- V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4)
- Euphoria warning: extreme positivity (+1.00) + overbought RSI 82
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $28.46
- Stop
- $27.32
The stock trades at 20.6× trailing but 15.1× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 82 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-11-04 — shown for context, not personalized investment advice.
PHG at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $27.82B
- P/E (fwd)
- 15.1
- P/E (ttm)
- 20.6
- 52-week range
- $23.62–$33.44
- Off 52-week high
- 14.9%
- RSI (14)
- 82
- Volume vs avg
- 1.47×
- Score today
- 5.9/10